Where does Vision RT Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Vision RT Limited ranks #7,798 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Vision RT Limited hold?

Vision RT Limited holds 42 US utility patents granted between 2015 and 2025, spanning 9 technology areas.

What is Vision RT Limited's Innovation Score?

Vision RT Limited has an Innovation Score of 40.2 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Vision RT Limited focus on?

Vision RT Limited's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 41 patents, ranking #90 of 1,943 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Vision RT Limited's patent grant rate increasing or decreasing?

Vision RT Limited's recent grant velocity is +64% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Vision RT Limited's patents?

Vision RT Limited's patents average 13.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Vision RT Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Vision RT Limited

USPTO PatentsView assignee record - 42 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Vision ranks #7,798 of 49,997 tracked US assignees by granted-patent volume, with 42 patents across 9 technology areas.

#7,798
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.2/100): 13.8
avg claims per patent: +64%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7798 · Foreign Corporation #7,798 · 42 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 42 grants
UPPER-Q #7,798/49,997
PHOTO-FINISH University of…
CPC-NARROW A61N · 9 areas
INNOV-PAR 40.2/100
CLAIMS-RICH 13.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +64% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: University of Strathclyde (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Vision’s 40.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.0 pts (32%) Velocity 8.3 pts (21%) Breadth 10.6 pts (26%) Claim depth 8.3 pts (21%)

Qualcomm Incorporated · highest

85
Ai Cure · near

40
Carl Zeiss MultiSEM · near

40
Conagen · near

40
Tarana Wireless · near

40
Vision RT · this assignee

40
3D Lighting… · lowest

7

What this shows Vision's Innovation Score is 40.2/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Vision?

Each dot is one of Vision’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Vision’s own 13.8 claims/patent is at or below the 17.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Vision vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Vision's grants concentrate

Vision RT Limited is a focused PatentsView assignee: 9 CPC subclasses with 97.6% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2023 (7 grants) versus a trough of 1 in 2015. By volume, Vision sits between University of Strathclyde and Wind River Systems, Inc..

Vision's three-year grant acceleration

Vision RT Limited shows 15 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

University of Str…

42
University of Sur…

42
Viavi Solutions UK

42
Visa Europe

42
Veris Industries

42
Vorbeck Materials

42
Wayne Fueling Sys…

42
Wind River Systems

42
Vision RT ◀

42

What this shows Vision holds 42 patents at rank #7,796, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Vision

By rank, the assignees closest to #7,796 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Vision's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Vision, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Vision ranks #90 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

Ai Cure Technologies LLC 40 Conagen Inc. 40 Tarana Wireless, Inc. 40 Carl Zeiss MultiSEM GmbH 40

Vision's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Vision RT Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	2.4%
2016	2	4.8%
2017	4	9.5%
2018	3	7.1%
2019	4	9.5%
2020	4	9.5%
2021	4	9.5%
2022	3	7.1%
2023	7	16.7%
2024	5	11.9%
2025partial year	5	11.9%

Which technologies does Vision RT Limited patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 41

A61B - DIAGNOSIS; SURGERY; Identification 33

G06T - Image Data Processing OR Generation, IN General 29

H04N - Pictorial Communication, e.g. Television 14

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 4

G05B - Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements 3

B25J - MANIPULATORS; Chambers Provided With Manipulation Devices 3

G01T - Measurement OF Nuclear OR X-radiation 2

A61G - Transport, Personal Conveyances, OR Accommodation Specially Adapted FOR Patients OR Disabled Persons ; Operating Tables OR CHAIRS; Chairs FOR DENTISTRY; Funeral Devices 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Vision RT Limited's patent record in context - here's where to go next.

Vision RT Limited's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 97.6% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #7,798 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Vision RT Limited against University of Strathclyde, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.